Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified

Zoetis

(

ZTS

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Zoetis as such a stock due to the following factors:

  • ZTS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $129.6 million.
  • ZTS has traded 1.6 million shares today.
  • ZTS is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ZTS with the Ticky from Trade-Ideas. See the FREE profile for ZTS NOW at Trade-Ideas

More details on ZTS:

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. The stock currently has a dividend yield of 0.9%. ZTS has a PE ratio of 31.

The average volume for Zoetis has been 2.8 million shares per day over the past 30 days. Zoetis has a market cap of $18.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.82 and a short float of 0.6% with 1.44 days to cover. Shares are up 15.2% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.